WO1998024912A3 - Vaccin contre la peste obtenu par recombinaison - Google Patents

Vaccin contre la peste obtenu par recombinaison Download PDF

Info

Publication number
WO1998024912A3
WO1998024912A3 PCT/US1997/022617 US9722617W WO9824912A3 WO 1998024912 A3 WO1998024912 A3 WO 1998024912A3 US 9722617 W US9722617 W US 9722617W WO 9824912 A3 WO9824912 A3 WO 9824912A3
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant
present
cells
viruses
molecules
Prior art date
Application number
PCT/US1997/022617
Other languages
English (en)
Other versions
WO1998024912A2 (fr
Inventor
Elizabeth J Haanes
Rex E Thomas
Jorge E Osorio
Original Assignee
Heska Corp
Elizabeth J Haanes
Rex E Thomas
Jorge E Osorio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp, Elizabeth J Haanes, Rex E Thomas, Jorge E Osorio filed Critical Heska Corp
Priority to AU55979/98A priority Critical patent/AU5597998A/en
Publication of WO1998024912A2 publication Critical patent/WO1998024912A2/fr
Publication of WO1998024912A3 publication Critical patent/WO1998024912A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La présente invention se rapporte à un vaccin obtenu par recombinaison et conçu pour protéger les animaux contre la peste. Cette invention se rapporte plus particulièrement à des molécules recombinées contenant des molécules isolées d'acide nucléique codant des protéines issues de bactéries du genre Yersinia, Pasteurella ou Francisella, exprimées dans des cellules eucaryotes. Selon une réalisation, la molécule recombinée est un génome de virus animal; selon une autre réalisation, la molécule recombinée est un plasmide recombiné. La présente invention se rapporte également à des virus recombinés comportant un génome de virus animal recombiné et à des cellules recombinées comportant soit un virus recombiné soit un plasmide recombiné. La présente invention se rapporte enfin à des compositions thérapeutiques comportant des molécules, virus et cellules recombinés ainsi qu'à des procédés de protection des animaux contre la peste.
PCT/US1997/022617 1996-12-04 1997-12-04 Vaccin contre la peste obtenu par recombinaison WO1998024912A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU55979/98A AU5597998A (en) 1996-12-04 1997-12-04 Recombinant plague vaccine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76711596A 1996-12-04 1996-12-04
US08/767,115 1996-12-04

Publications (2)

Publication Number Publication Date
WO1998024912A2 WO1998024912A2 (fr) 1998-06-11
WO1998024912A3 true WO1998024912A3 (fr) 1998-09-11

Family

ID=25078527

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/022617 WO1998024912A2 (fr) 1996-12-04 1997-12-04 Vaccin contre la peste obtenu par recombinaison

Country Status (2)

Country Link
AU (1) AU5597998A (fr)
WO (1) WO1998024912A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1394500A (en) * 1998-11-18 2000-06-05 Innature Limited Product
US7344718B2 (en) 2003-01-31 2008-03-18 University Of North Dakota Yersinia species compositions
JP2008528512A (ja) 2005-01-21 2008-07-31 エピトピックス，リミティド ライアビリティ カンパニー エルシニアｓｐｐ．ポリペプチド及び使用方法
WO2009062112A2 (fr) 2007-11-09 2009-05-14 The Salk Institute For Biological Studies Utilisation d'inhibiteurs de récepteurs tam en tant qu'antimicrobiens
US9211327B2 (en) 2011-06-22 2015-12-15 University Of North Dakota Use of YSCF, truncated YSCF and YSCF homologs as adjuvants
US9328149B2 (en) * 2013-07-12 2016-05-03 The Catholic University Of America Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines
CN114560932B (zh) * 2022-02-18 2023-09-12 中国人民解放军军事科学院军事医学研究院 一株鼠疫中和抗体及其应用

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989007140A1 (fr) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Systeme d'expression par genes (en particulier pour la proteine de rotavirus vp7) employant un peptide de signal etranger et eventuellement une sequence d'ancrage transmembrane
WO1990002484A1 (fr) * 1988-09-06 1990-03-22 Washington University Immunisation par voie orale a l'aide de plantes transgeniques
WO1993001284A1 (fr) * 1991-07-09 1993-01-21 Cornell Research Foundation, Inc. Vaccin viral de recombinaison
WO1993008290A1 (fr) * 1991-10-16 1993-04-29 University Of Saskatchewan Immunogenicite renforcee par l'utilisation de chimeres comprenant des leucotoxines
US5266313A (en) * 1987-02-03 1993-11-30 The United States Of America As Represented By The Department Of Health And Human Services Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
WO1994016737A1 (fr) * 1993-01-26 1994-08-04 Weiner David B Compositions et procedes d'administration de matieres genetiques
WO1994024296A2 (fr) * 1993-04-19 1994-10-27 University Of Saskatchewan Vaccins de recombinaison contre l'herpesvirus bovin de type 1
EP0652287A2 (fr) * 1993-09-22 1995-05-10 American Home Products Corporation Vecteurs poxviraux et leur utilisation comme vaccin contre l'infection par le virus de la péritonite infectieuse féline
WO1995018231A1 (fr) * 1993-12-24 1995-07-06 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Compositions pour vaccins comprenant des vecteurs bacteriens vivants pour la protection contre l'infection a yersinia pestis
WO1996021356A1 (fr) * 1995-01-13 1996-07-18 Vanderbilt University Procedes et compositions destines a induire des reponses immunitaires des muqueuses
WO1996028551A1 (fr) * 1995-03-13 1996-09-19 The Secretary Of State For Defence Vaccins contre la peste

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266313A (en) * 1987-02-03 1993-11-30 The United States Of America As Represented By The Department Of Health And Human Services Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
WO1989007140A1 (fr) * 1988-02-05 1989-08-10 Commonwealth Scientific And Industrial Research Or Systeme d'expression par genes (en particulier pour la proteine de rotavirus vp7) employant un peptide de signal etranger et eventuellement une sequence d'ancrage transmembrane
WO1990002484A1 (fr) * 1988-09-06 1990-03-22 Washington University Immunisation par voie orale a l'aide de plantes transgeniques
WO1993001284A1 (fr) * 1991-07-09 1993-01-21 Cornell Research Foundation, Inc. Vaccin viral de recombinaison
WO1993008290A1 (fr) * 1991-10-16 1993-04-29 University Of Saskatchewan Immunogenicite renforcee par l'utilisation de chimeres comprenant des leucotoxines
WO1994016737A1 (fr) * 1993-01-26 1994-08-04 Weiner David B Compositions et procedes d'administration de matieres genetiques
WO1994024296A2 (fr) * 1993-04-19 1994-10-27 University Of Saskatchewan Vaccins de recombinaison contre l'herpesvirus bovin de type 1
EP0652287A2 (fr) * 1993-09-22 1995-05-10 American Home Products Corporation Vecteurs poxviraux et leur utilisation comme vaccin contre l'infection par le virus de la péritonite infectieuse féline
WO1995018231A1 (fr) * 1993-12-24 1995-07-06 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Compositions pour vaccins comprenant des vecteurs bacteriens vivants pour la protection contre l'infection a yersinia pestis
WO1996021356A1 (fr) * 1995-01-13 1996-07-18 Vanderbilt University Procedes et compositions destines a induire des reponses immunitaires des muqueuses
WO1996028551A1 (fr) * 1995-03-13 1996-09-19 The Secretary Of State For Defence Vaccins contre la peste

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WILLIAMSON E.D. ET AL.: "A new improved sub-unit vaccine for plague: the basis of protection", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 12, 1 January 1995 (1995-01-01), pages 223 - 230, XP000573083 *

Also Published As

Publication number Publication date
WO1998024912A2 (fr) 1998-06-11
AU5597998A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
DK1783225T3 (da) Strukturprotein fra AAV, dets fremstilling og anvendelse
WO1999020766A3 (fr) SEQUENCES D'ACIDES NUCLEIQUES MODIFIES ET PROCEDES PERMETTANT D'ACCROITRE LES NIVEAUX D'ARNm ET L'EXPRESSION DES PROTEINES DANS LES SYSTEMES CELLULAIRES
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
RU95108217A (ru) Дефектный рекомбинантный аденовирус, линия клеток, фармацевтическая композиция
NO962791D0 (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
CA2339791A1 (fr) Procedes et compositions permettant de cloner des molecules d'acide nucleique
WO2001079444A3 (fr) Proteines hybrides d'albumine
DK0910406T3 (da) Rekombinante hunde-herpesvirus
WO2002022821A3 (fr) Peptides antimicrobiens et methodes d'utilisation
ATE270342T1 (de) Endosomolytisch wirksame partikel
WO2002097048A3 (fr) Proteines derivees de l'immunoglobuline anti-p40, compositions, procedes et utilisations
GB2396814A (en) Vaccine
WO2002086144A3 (fr) Compositions et procedes destines au clonage recombinant de molecules d'acides nucleiques
AUPN477695A0 (en) Gene therapy
NO983946L (no) Parapoxviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
WO2000053776A3 (fr) Nouveaux genes humains du type kallikreine
WO1998024912A3 (fr) Vaccin contre la peste obtenu par recombinaison
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
WO1994013812A3 (fr) Nouveaux genes de l'entomopoxvirus, nouvelles proteines et leurs procedes d'utilisation
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
WO1995032297B1 (fr) Nouveau fragment chromosomique et son utilisation comme vecteur
CA2245545A1 (fr) Produit vaccinal issu du gene 63 actif contre le virus varicelle-zona
WO2000066743A3 (fr) Vecteurs d'expression virale
WO1999057284A3 (fr) Virus attenue de la grippe
HUP9904201A1 (hu) Génterápiában használható, egy exogén nukleinsavat genomjában beépítve tartalmazó rekombináns vírus és egy nem virális és nem plazmid transzfektáló szer kombinációját tartalmazó transzfektáló készítmény

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page

Free format text: ADD INID NUMBER (63) "RELATED BY CONTINUATION (CON) OR CONTINUATION-IN-PART (CIP) TO EARLIER APPLICATION" WHICH WAS INADVERTENTLY OMITTED FROM THE FRONT PAGE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09319290

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA